DAO and Parkinson disease: Alternatively, to avoid the potential toxicity of D-Ser administration, another possible route might be pursued in PD therapeutics through the inhibition of DAAO by sodium benzoate, which has been already successfully applied in the treatment of schizophrenia and Alzheimer’s disease53.